Register entry
Pfizer Ireland Pharmaceuticals Unlimited Company
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 71
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
7171 active NDC listings: 50 drug for further processing, 21 bulk ingredient. By marketing category: DRUG FOR FURTHER PROCESSING 50, BULK INGREDIENT 21.
| Dosage form | NDCs |
|---|---|
| powder | 21 |
| capsule | 12 |
| capsule, extended release | 7 |
| tablet | 7 |
| tablet, extended release | 7 |
| tablet, film coated | 7 |
| tablet, sugar coated | 7 |
| paste | 1 |
| tablet, film coated, extended release | 1 |
| tablet, for suspension | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| pfizer ireland pharmaceuticals unlimited company | 71 |
Catalogue
Marketed products
71| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Azithromycin | powder | 60715-3150BULK INGREDIENT |
| - | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | tablet, sugar coated | 42816-1105DRUG FOR FURTHER PROCESSING |
| - | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | tablet, sugar coated | 42816-1106DRUG FOR FURTHER PROCESSING |
| - | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | tablet, sugar coated | 42816-1107DRUG FOR FURTHER PROCESSING |
| - | CONJUGATED ESTROGENS and MEDROXYPROGESTERONE ACETATE | tablet, sugar coated | 42816-1108DRUG FOR FURTHER PROCESSING |
| - | Crizotinib | powder | 60715-1551BULK INGREDIENT |
| - | Dofetilide | powder | 60715-2811BULK INGREDIENT |
| - | Doxycycline Hyclate | powder | 60715-0445BULK INGREDIENT |
| - | FESOTERODINE FUMARATE | powder | 60715-0242BULK INGREDIENT |
| - | Palbociclib | powder | 60715-0188BULK INGREDIENT |
| - | SIROLIMUS | tablet, sugar coated | 42816-1040DRUG FOR FURTHER PROCESSING |
| - | SIROLIMUS | tablet, sugar coated | 42816-1041DRUG FOR FURTHER PROCESSING |
| - | SIROLIMUS | tablet, sugar coated | 42816-1042DRUG FOR FURTHER PROCESSING |
| - | Tafamidis | powder | 60715-0647BULK INGREDIENT |
| - | Tafamidis | powder | 60715-4344BULK INGREDIENT |
| - | Temsirolimus | powder | 60715-1125BULK INGREDIENT |
| - | VENLAFAXINE HYDROCHLORIDE | capsule, extended release | 42816-0833DRUG FOR FURTHER PROCESSING |
| - | VENLAFAXINE HYDROCHLORIDE | capsule, extended release | 42816-0836DRUG FOR FURTHER PROCESSING |
| - | VENLAFAXINE HYDROCHLORIDE | capsule, extended release | 42816-0837DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet | 42816-0029DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet | 42816-0055DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet, extended release | 42816-0057DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet, extended release | 42816-0059DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet, extended release | 42816-0066DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet, extended release | 42816-0068DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet | 42816-0090DRUG FOR FURTHER PROCESSING |
| - | alprazolam | tablet | 42816-0094DRUG FOR FURTHER PROCESSING |
| - | apixaban | tablet, film coated | 42816-0893DRUG FOR FURTHER PROCESSING |
| - | apixaban | tablet, film coated | 42816-0894DRUG FOR FURTHER PROCESSING |
| - | apixaban | tablet, for suspension | 42816-1028DRUG FOR FURTHER PROCESSING |
| - | conjugated estrogens | powder | 42816-0101DRUG FOR FURTHER PROCESSING |
| - | conjugated estrogens | tablet, film coated | 42816-1100DRUG FOR FURTHER PROCESSING |
| - | conjugated estrogens | tablet, film coated | 42816-1101DRUG FOR FURTHER PROCESSING |
| - | conjugated estrogens | tablet, film coated | 42816-1102DRUG FOR FURTHER PROCESSING |
| - | conjugated estrogens | tablet, film coated | 42816-1103DRUG FOR FURTHER PROCESSING |
| - | conjugated estrogens | tablet, film coated | 42816-1104DRUG FOR FURTHER PROCESSING |
| - | crisaborole | powder | 60715-3211BULK INGREDIENT |
| - | dacomitinib | powder | 60715-0015BULK INGREDIENT |
| - | desvenlafaxine succinate | tablet, extended release | 42816-1210DRUG FOR FURTHER PROCESSING |
| - | desvenlafaxine succinate | tablet, extended release | 42816-1211DRUG FOR FURTHER PROCESSING |
| - | desvenlafaxine succinate | tablet, extended release | 42816-1222DRUG FOR FURTHER PROCESSING |
| - | fluconazole | powder | 60715-0020BULK INGREDIENT |
| - | nirmatrelvir | powder | 60715-2085BULK INGREDIENT |
| - | norgestrel | tablet | 42816-7717DRUG FOR FURTHER PROCESSING |
| - | norgestrel | tablet | 42816-8101DRUG FOR FURTHER PROCESSING |
| - | pegvisomant | paste | 64052-001BULK INGREDIENT |
| - | piroxicam | powder | 60715-3270BULK INGREDIENT |
| - | prazosin hydrochloride | powder | 60715-0011BULK INGREDIENT |
| - | propranolol hydrochloride | capsule, extended release | 42816-0470DRUG FOR FURTHER PROCESSING |
| - | propranolol hydrochloride | capsule, extended release | 42816-0471DRUG FOR FURTHER PROCESSING |
| - | propranolol hydrochloride | capsule, extended release | 42816-0473DRUG FOR FURTHER PROCESSING |
| - | propranolol hydrochloride | capsule, extended release | 42816-0479DRUG FOR FURTHER PROCESSING |
| - | talazoparib tosylate | powder | 60715-2345BULK INGREDIENT |
| - | tigecycline | powder | 60715-1001BULK INGREDIENT |
| - | tofacitinib | tablet, film coated, extended release | 42816-0501DRUG FOR FURTHER PROCESSING |
| - | tofacitinib citrate | powder | 60715-1000BULK INGREDIENT |
| - | triazolam | tablet | 42816-0017DRUG FOR FURTHER PROCESSING |
| - | voriconazole | powder | 60715-1700BULK INGREDIENT |
| - | ziprasidone | capsule | 42816-0131DRUG FOR FURTHER PROCESSING |
| - | ziprasidone | capsule | 42816-1134DRUG FOR FURTHER PROCESSING |
| - | ziprasidone | capsule | 42816-1329DRUG FOR FURTHER PROCESSING |
| - | ziprasidone | capsule | 42816-1933DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-0052DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-0054DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-0056DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-0058DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-2001DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-2002DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-2003DRUG FOR FURTHER PROCESSING |
| - | ziprasidone hydrochloride | capsule | 42816-2004DRUG FOR FURTHER PROCESSING |
| - | ziprasidone mesilate | powder | 60715-1203BULK INGREDIENT |
Compare
Other companies listing alprazolam
- Viatris Inc.18 sites · 135 NDC
- Par Health USA, LLC5 sites · 211 NDC
- Centaur Pharmaceuticals Private Limited4 sites · 19 NDC
- Fermion Oy3 sites · 20 NDC
- Proficient Rx LP1 site · 1,729 NDC
- ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
- Aphena Pharma Solutions - Tennessee, LLC0 sites · 795 NDC
- Mylan Pharmaceuticals, Inc.0 sites · 489 NDC
- Pharmacia and Upjohn Company LLC0 sites · 148 NDC
Enquiry
Common questions
- Is Pfizer Ireland Pharmaceuticals Unlimited Company FDA approved?
- Pfizer Ireland Pharmaceuticals Unlimited Company holds no registered establishment of its own; 71 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Pfizer Ireland Pharmaceuticals Unlimited Company make?
- 71 products are listed under Pfizer Ireland Pharmaceuticals Unlimited Company in the openFDA NDC Directory, most often as powder; capsule; capsule, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.